ZOOM ON Video – YUMAB
YUMAB is an innovative biotech company developing next-generation therapeutic antibodies for clients and partners worldwide.
Their platform includes proprietary library technologies, such as fully human antibody libraries, patient-derived libraries, and immune libraries from different species.
YUMAB integrates all technologies from discovery through engineering and AI-enabled lead optimization, providing developability-approved therapeutic lead candidates.
ZOOM ON – MImabs
MImAbs is a French CRO with 12 years of innovation in antibody science and a strong partnership-driven mindset. As part of Janvier Group Biosciences, we leverage cutting-edge technologies and deep expertise to support drug-development programs from early antibody discovery to advanced engineering and comprehensive characterization.
Experts’ corner : Les ADC/ ADC Bispécifiques
The Experts Corner – Découvrez notre échange avec Alain Beck des Laboratoires Pierre Fabre sur les ADC/ADC Bispécifiques.